Mode
Text Size
Log in / Sign up
Phase 3 Completed N=438 Randomized Basic Science

Impact of Very Low Nicotine Content Cigarettes in a Complex Marketplace

Tobacco Smoking · Nicotine Dependence
Source: ClinicalTrials.gov NCT03272685 ↗
Enrolled (actual)
438
Serious AEs
3.0%
Results posted
Aug 2024
Primary outcomePrimary: Cigarettes Per Day (CPD) — 7.05; 12.95 cigarettes per day
◆ Published Evidence
Established
23citations · ~12 / year
Reduced nicotine in cigarettes in a marketplace with alternative nicotine systems: randomized clinical trial.
Lancet regional health. Americas · 2024 · Open access · Likely link

Summary

This project will examine the impact of very low nicotine content (VLNC) cigarettes in a complex tobacco and nicotine product marketplace. We will compare the number of cigarettes smoked and cigarette-free days in an experimental marketplace that contains VLNC cigarettes versus normal nicotine content (NNC) cigarettes.

Linked Publications (3)

  • Reduced nicotine in cigarettes in a marketplace with alternative nicotine systems: randomized clinical trial.
    Lancet regional health. Americas · 2024 · 23 citations · Open access · Likely link
  • Secondary analysis of a randomized clinical trial of very low nicotine cigarettes: Outcomes across social and demographic groups.
    Preventive medicine · 2025 · 3 citations · Open access · Likely link
  • Titration of nicotine intake in smokers switching to reduced nicotine content cigarettes with access to alternative nicotine systems: Secondary analysis of a randomized clinical trial.
    Addiction (Abingdon, England) · 2026 · 0 citations · Open access · Likely link

Outcome Measures

OutcomeResultp-value
PRIMARY
Cigarettes Per Day (CPD)
7.05; 12.95
PRIMARY
Number of Smoke-free Days
18.6; 5.1
SECONDARY
Percent Change in 2-cyanoethyl-mercapturic Acid (CEMA)
-34; 8
SECONDARY
Study Cigarettes Per Day
5.33; 12.42
SECONDARY
Seven Day Point-prevalence CO-verified Abstinence
41; 15

Eligibility Criteria

Inclusion Criteria

  • Male or female;
  • 18/21 (legal age to purchase tobacco at site);
  • Biochemically confirmed smoker.

Exclusion Criteria

  • Unstable health condition;
  • Unstable medications;
  • Pregnant or nursing.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03272685) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search